Cibus, Inc. (CBUS)
1.61
+0.16
(+11.03%)
USD |
NASDAQ |
Dec 04, 16:00
1.61
0.00 (0.00%)
After-Hours: 05:35
Cibus EPS Diluted (Quarterly): -0.4448 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Phio Pharmaceuticals Corp. | -0.4374 |
| CEL-SCI Corp. | -1.365 |
| AIM ImmunoTech, Inc. | -1.569 |
| IGC Pharma, Inc. | -0.0201 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -24.30M |
| Revenue (Quarterly) | 0.615M |
| Total Expenses (Quarterly) | 24.16M |
| Enterprise Value | 322.07M |
| Gross Profit Margin (Quarterly) | -126.7% |
| Profit Margin (Quarterly) | -3.95K% |
| Earnings Yield | -199.9% |
| Normalized Earnings Yield | -172.75 |